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ABSTRACT
Inflammation has been widely reported to regulate adipocyte functions in adipose tissue.
Our early study suggests that NF-κB signaling pathway is activated by inflammation and
involved in inhibition of insulin sensitivity in adipocytes. NF-κB was found to inhibit PPARγ
function through several possible mechanisms in 3T3-L1 adipocytes. To test this possibility in
vivo, we increased the NF-κB activity in adipocytes in transgenic mice by expression of NF-κB
p65 subunit under the aP2 gene promoter.
The phenotype study shows that the food intake, physical activity and development are
similar in the two groups. The reproductivity was not different in the two groups. However, the
body weight gain and fat content increment are apparently less in the Tg mice, which was
associated with a significant increase in energy expenditure and a defect in adipogenesis.
Chronic inflammation was observed in the adipose tissue of Tg mice with macrophage
infiltration and secretion of inflammatory cytokines. The data suggest that NF-κB p65 inhibits
PPARγ function in adipose tissue, and prevents adulthood and diet-induced obesity. However, it
does not provide benefit to the protection of systemic insulin sensitivity.
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CHAPTER 1
INTRODUCTION OF BACKGROUND
OBESITY
Obesity has been a serious health threat to general public all over the world. A survey
conducted by USCDC (United States Centers for Disease Control) estimated that 66% of the U.S.
adult population are overweight, with 32.3% in obesity (body mass index (BMI) ≥ 30 kg/m2) [1].
Obesity may reduce life quality and lead to premature mortality through several chronic diseases.
It was reported that the United States government has to spend $93 billion or 9.1% of all
healthcare dollars on the disease associated with obesity [2].
It has been well accepted that people with abdominal obesity are at higher risk for heart
disease, type 2 diabetes, hypertension and hyperlipidemia compared to people with subcutaneous
obesity [3]. Although the mechanism for the health difference between visceral fat and
subcutaneous fat remains unclear, literature suggests that visceral adipose tissue has a higher rate
of lipolysis, which may promote elevation of non-esterified fatty acids (NEFAs) in the plasma,
thus inducing very-low-density lipoprotein (VLDL) production, hepatic glucose output (HGO)
and decreasing peripheral insulin sensitivity [4]. Therefore, the study of adipose tissue has been
very active in the obesity research field.
ADIPOSE TISSUE FUNCTION
Adipose tissues are divided into white and brown types according to their cell types. The
vast majority of white adipose tissue (WAT) volume is composed of lipid-laden adipocytes. But
WAT also contains a significant stromovascular fraction (SVF), including preadipocytes,
endothelial cells, smooth muscle cells, fibroblasts, leukocytes and macrophages[5]. The
macrophage is the primary cell type in inflammation of adipose tissue. Activated macrophages
1

can secrete a plethora of cytokines such as TNF-α, IL-1 and IL-6 [6]. Several studies identified
macrophages as the predominant producer for TNF-α and interleukin-6 in adipose tissue [7, 8].
In humans adipose macrophage density is positively correlated with BMI and insulin resistance
[9] [10].
The major functions of WAT include energy storage and endocrine (secretion of
hormones/adipokines). The hormones/adipokines control energy balance, glucose and lipid
metabolism. The adipokines include leptin, adiponectin, resistin, tumor necrosis factor-alpha
(TNF-α), plasminogen activator inhibitor-1 (PAI-1), MCP-1, macrophage migration inhibitory
factor (MIF), interleukin-8 (IL-8), IL-6, IL-1 and vascular endothelial growth factor (VEGF).
Leptin acts mainly on the central nervous system to regulate food intake and energy
expenditure. Leptin is also able to control TNF-α production and macrophage activation. It thus
contributes to the limitation of inflammation states in obesity [11]. Adiponectin has multiple
effects such as improving insulin sensitivity and protecting against atherosclerosis. Adiponectin
can activate AMPK and enhance lipid oxidation [12]. Circulating adiponectin levels are
decreased in obese and/or type 2 diabetic patients and in patients with coronary heart diseases.
Serum resistin is elevated in obesity and involved in pathogenesis of insulin resistance. Resistin
can also upregulate the expression of Suppressor of Cytokine Signaling-3 (SOCS-3), a wellknown negative regulator of insulin signaling [13].
Brown adipocytes contain a high density of mitochondria, but less triglyceride. Their
major function is to generate heat in the adaptive thermogenesis for maintenance of body
temperature. Brown adipose tissue (BAT) is named after its color due to a high content of
mitochondria. Upon cold stimulus, heat production in the animals is generated by BAT via the
SNS-stimulated release of catecholamines. Such a process requires accelerated oxidation of
2

stored lipids within brown adipocytes in numerous mitochondria. Brown adipose cells
exclusively express uncoupling protein-1 (UCP-1), a proton transporter that uncouples electron
transport from ATP production, facilitating the energy to dissipate as heat. Based on the critical
role of BAT in metabolism, BAT is now a hot point in the study of tumor and cancer [14, 15].
INFLAMMATION AND ADIPOSE TISSUE FUNCTION
Inflammation has been already detected with inflammatory cytokines such as TNF-α, IL1 and IL-6 in expanded adipose tissue [6]. The expansion of WAT in obesity results in tissue
hypoperfusion and hypoxia, resulting in macrophages infiltration and expression of
inflammatory cytokines [16, 17]. The serum free fatty acids (FFAs) level is also elevated in
obesity, which induces lipotoxicity and oxidative stress, thus inducing inflammation and
impairing the insulin effect [18, 19]. Moreover, inflammatory mediators and lipid accumulation
can affect the endoplasmic reticulum (ER), causing ER stress and enhancing inflammation [20,
21].
Obesity is also associated with increased numbers of apoptotic and necrotic adipocytes in
WAT and BAT, which may induce chemoattractant signals that recruit monocytes[16]. There is
evidence to suggest that macrophages alter inflammatory status in adipose tissue by promoting
TNF-α, IL-6 secretion and ectopic storage of lipid within liver and muscle tissues [22]. As a
result, enhanced secretion of some interleukins and inflammatory cytokines as well as increased
circulating levels of many cytokines including TNF-α, IL-1, IL-6 and IL-8 happens in WAT and
induces insulin resistance.
Tumor necrosis factor-alpha (TNF-α) is a multifunctional proinflammatory cytokine
produced predominantly by monocytes/macrophages. It has been reported to be involved as an
important regulatory cytokine in many cellular and biological processes such as cell
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differentiation, proliferation, apoptosis, energy metabolism and immune function. The role of
TNF-α in BAT is still debatable. Some studies supported that TNF-α can reduce mitochondrial
biogenesis and function in WAT and BAT through inhibition of eNOS expression [23]. TNF-α
also impairs BAT thermogenesis via downregulation of UCP-1 and beta 3-AR expression [24,
25]. It was reported that TNF-α could compromise BAT thermogenesis by promoting Brown cell
atrophy or by impairing BAT differentiation or inducing BAT apoptosis [26, 27]. Conflicting
opinions argue that TNF-α promotes BAT thermogenic activity, probably by increasing UCP
proteins expression [28], but some studies on catabolic states tend to believe that TNF-α affects
central nervous system to propel thermogenesis and energy expenditure [29].
As a contrast, there are numerous studies aiming at the effect of TNF-α on WAT. In dietinduced diabetic rodents, TNF-α is elevated in WAT and might mediate obesity-related insulin
resistance [30]. In obese mice with a targeted null mutation in the genes for TNF-α and its p55
and p75 receptors, a significantly improved insulin sensitivity was observed in both diet-induced
obesity and the ob/ob model of obesity due to the deficiency of TNF-α. TNF-α -deficient mice
had lower levels of circulating free fatty acids and they demonstrated less obesity-related
reduction in insulin receptor signaling in muscle and fat tissues. Furthermore, relevant
experiments in vivo and in vitro supported that TNF-α might affect different sites of the insulin
signaling pathway such as inhibiting of the insulin-stimulated tyrosine kinase activity of the
insulin receptor, downregulating the expression of the insulin-sensitive glucose transporter Glut4
[31].
In addition to its effect in the local area, adipose tissue-derived TNF-α can regulate
systemic energy homeostasis indirectly by affecting both adipose function and expandability. In
the series of studies on catabolic disease, TNF-α was initially proved to play a role in cellular
4

metabolism. Mounting evidences show that TNF-α can affect glucose homeostasis in
adipocytes[32], stimulates lipolysis[33] and inhibits adipocyte differentiation and lipogenesis.
Lipid metabolism in adipose tissue is composed of three main parts: FFA uptake,
lipogenesis and lipolysis. TNF-α regulates lipid metabolism in adipocytes by inhibiting FFA
uptake and lipogenesis, as well as promoting lipolysis. Lipoprotein lipase (LPL) is closely
related to FFA uptake into adipocyte. The expression of LPL gene has been shown to be
suppressed by TNF-α [34]. Although the levels of hormone sensitive lipase (HSL) and adipose
triglyceride lipase (ATGL), two proteins that mediate lipolysis, are downregulated when PPARγ
activity is inhibited, TNF-α may still induce lipolysis by increasing cAMP concentration and
impairing the preventative effect of perilipins on lipolysis [35]. These actions of TNF-α may be
mediated via serine kinases JNK, ERK1/2 and NF-κB [36, 37]. The inhibition of PPARγ by
TNF-α might also contribute to the decreased expression of perilipin [38]. Furthermore, fatty
acid synthase (FAS) is downregulated by TNF-α, suggesting that lipogenesis might also be
reduced in the presence of TNF-α [39].
TNF-α may also suppress adipogenesis by preventing the differentiation of preadipocytes
into mature adipocytes, which is associated with the inhibition of PPARγ. TZD treatment can
antagonize this effect [40]. And the expressions of other genes responsible for the function of
adipocytes such as aP2, ATGL are also inhibited as a consequence of the downregulation of
PPARγ and C/EBPα [41]. Another mechanism involved in the anti-adipogenesis effect of TNF-α
is the β-catenin/TCF pathway. Activation of this pathway was confirmed to inhibit PPARγ
expression and lipid accumulation both in vitro and in vivo [42].
Peroxisome proliferator-activated receptor gamma (PPARγ) is a transcription factor
belonging to the nuclear receptor superfamily. PPARγ is essential in adipogenesis and
5

recognized as a major target for the insulin-sensitizing effects of the thiazolidinediones.
Heterozygous PPARγ -deficient mice are protected from high-fat diet (HFD)-induced adipocyte
hypertrophy, obesity and insulin resistance, suggesting that PPARγ may have a vital role in
adipocyte hypertrophy, obesity and insulin resistance [43]. PPARγ is also one of the target genes
of TNF-α [44]. TNF-α regulates PPARγ directly either by inhibiting the expression of PPARγ
mRNA or suppressing its transcriptional activity. The TNF-α activity is dependent on activation
of the nuclear factor kappa B (NF-κB) pathway [45].
NF-κB mediates a large amount of stimulis including the TNF-α signal in many immune
or inflammatory conditions involving autoimmune arthritis, asthma, lung fibrosis,
glomerulonephritis, atherosclerosis, Crohn’s and insulin resistance. Inhibition of NF-κB
salicylates was demonstrated to reverse insulin resistance [46]. After treatment with NF-κB
inhibitors for 18 hours, production of IL-6, IL-8, and TNF-α was significantly reduced in
adipocytes and skeletal muscle cells. And NF-κB p65 DNA-binding activity was also reduced.
Moreover, NF-κB inhibitor increased the adipose tissue and skeletal muscle expression of insulin
receptor-beta, suggesting NF-κB transcription pathway is a key regulator of IL-6, IL-8, and TNFα [47]. Recently, more research has come to concentrate on the association between NF-κB and
metabolism. Downregulation of NF-κB activity may attenuate the development of cachexia in
tumor-bearing humans and mice through inhibition of IL-6 and TNF-α synthesis, suggesting the
important role of NF-κB in metabolism [48-50].
In our previous studies, we have demonstrated that IKK inhibits the transcriptional
activity of PPARγ through activation of NF-κB (Gao JBC 2006). Using multiple systems, we
demonstrated that activation of NF-κB led to inhibition of PPARγ through several approaches.
NF-κB inhibits mRNA expression of PPARγ and this happens after overnight NF-κB activation.
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In an acute manner, activation of NF-κB leads to inhibition of the transcriptional activity of
PPARγ through activation of HDAC3. In the cytoplasm, HDAC3 is associated with IκBα. After
IκBα degradation in response to TNF-α, HDAC3 is subject to nuclear translocation, leading to a
subcellular redistribution of HDAC3. HDAC3 is known as a component of corepressor complex
for PPARγ [51]. In this case, the DNA-binding activity of PPARγ is not changed by NF-κB.
Additionally, activation of IKK/NF-κB also promotes degradation of PPARγ protein. Our
previous findings suggested that FFAs may use IKK/NF-κB pathway in the inhibition of PPARγ
function [52, 53].
Moreover, our study in 3T3-L1 adipocytes strongly supported that the transcriptional
coactivators and corepressors play a critical role in the inhibition of PPARγ by NF-κB. The κ
transcriptional activity of PPARγ depends on recruitment of the transcriptional coactivators
including SRC-1, SRC-2 and p300/CBP, which are also required by NF-κB [54]. Competition
for a limited amount of the coactivators is a common mechanism of cross-inhibition between the
two transcription factors, which might be the molecular basis that NF-κB deprives PPARγ of the
transcriptional coactivators. However, we currently gained results only in vitro. The condition in
vivo still needs further exploration.
The p50 (NF-ΚB1)/p65 (RELA) heterodimer is the most abundant form of the NF-κB
complex, which is inhibited by IκB proteins. Phosphorylation of serine residues on the IκB
proteins by kinases results in the degradation of the protein and thus allowing activation of the
NF-κB complex [55]. Activated NF-κB complex translocates into the nucleus and binds DNA at
kappa-B-binding motifs. The process requires the transcriptional coactivator CBP /p300
associating with NF-κB p65 subunit. Thus p65 serves as an essential functional subunit, which is
supported by many studies. In the transgenic knockout mouse line for p65, the lack of the protein
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led to embryonic lethality at 15-16 days of gestation due to massive degeneration of the liver due
to apoptosis [56]. Some investigations reported direct evidence for the involvement of p65 in
chronic intestinal inflammation in mice, suggesting that p65 antisense oligonucleotides might be
a potential molecular treatment of patients with Crohn disease [57]. Furthermore, p65/RelA can
directly bind to PPARγ-PGC1 complex and thus preventing it binding to PPARγ response
elements[58]. Therefore, the concentrated study on NF-κB P65 may further illustrate the role of
P65 in the function of NF-κB and its interaction with other subunits.
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CHAPTER 2
PHENOTYPE STUDY OF AP2-P65 TRANSGENIC MOUSE
INTRODUCTION
Inflammation regulates adipocyte functions in adipose tissue. Our early study suggests
that NF-κB signaling pathway is activated by inflammation and involved in inhibition of insulin
sensitivity in adipocytes. Moreover NF-κB was found to inhibit PPARγ function through several
possible mechanisms such as activation of nuclear corepressor and competition in coactivator in
3T3-L1 adipocytes. To test this possibility in vivo, we increased the NF-κB activity in adipocytes
in transgenic mice. This was achieved by expression of NF-κB p65 subunit under the aP2 gene
promoter.
The aP2-p65 transgenic mice (Tg mice) were utilized to study the phenotype and test the
inflammation activity in adipose tissue. The Tg and WT mice had no difference in size,
appearance and behavior at birth. The reproductiveity was not different in the two groups. The
phenotype study in adult mice was started at the age of 6 weeks, focusing on the body weight,
body composition, food intake, metabolic rate and adiposity. On chow diet, the food intake and
physical activity were similar in the two groups. However, the body weight gain and fat content
increment are apparently less in the Tg mice, which was associated with a significant increase in
energy expenditure and a defect in adipogenesis. Chronic inflammation was observed in the
adipose tissue of Tg mice with macrophage infiltration and secretion of inflammatory cytokines.
The mRNA levels of PPARγ as well as its target genes were remarkably depressed. When fed on
a high-fat diet, the Tg mice gained less fat and were protected from dietary obesity. The data
suggest that NF-κB p65 inhibits PPARγ function in adipose tissue, and prevents adulthood and

9

diet-induced obesity. However, it does not provide benefit to the protection of systemic insulin
sensitivity.
MATERIALS AND METHODS
Reagents: Rabbit polyclonal antibodies to NF-κB p65, p50 were purchased from Santa
Cruz Biotechnology. The18s and p65 primers for genotyping PCR was purchased from SigmaAldrich Corporation. Taqman Primers and probes for p65 (Mm00501346_m1) were obtained
from Applied Biosystems Incorporation. Real time RT-PCR reagents including MuLV reverse
transcriptase, RNAse inhibitor and PCR reagent were obtained from Applied Biosystems
(Branchburg, NJ).
Animals: Male C57BL/6J mice were purchased from the Jackson laboratory (Bar Harbor,
ME). All of the mice were housed in the animal facility at the Pennington Biomedical Research
Center with a 12:12-h light-dark cycle and constant temperature (22–24°C). The mice had free
access to water and diet (normal chow MF 5015 consisting of 13.4% of calories as fat or a high
fat diet D12331, Research Diets, New Brunswick, NJ), which contains 58% calories in fat.). All
procedures were performed in accordance with the National Institutes of Health guidelines for the
care and use of animals and were approved by the Institutional Animal Care and Use Committee
at the Pennington Biomedical Research Center. The mice were ear-punched for identification and
were kept four per cage.
aP2-p65 Constructs: The aP2-p65 plasmid construct was made by Gang Yu in the gene
regulation lab at the Pennington Biomdical Research Center. To generate the aP2 promoter–P65
expression construct, a 1.8kb mouse p65 cDNA was amplified by PCR and was placed at the
downstream of aP2 gene promoter in the aP2-PBSK vector at SpeI and Not I sites. The aP2-p65
expression cassette was then inserted into the Hind III/Not I sites in the multiple cloning region
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of pcDNA3.1 (+) plasmid to gain poly A signal. The plasmid (20 g) was digested with Hind III
(40 U) and Drd I (40 U) to isolate the aP2-p65-poly-A expression cassette. The digestion was
conducted in 100 μl reaction with Buffer 4 overnight (16 hrs). The product was resolved in an
agarose gel with 1X TAE buffer. The bands are shown in the picture. The DNA of aP2-PDGFpoly-A was the largest band, and was collected for making the transgenic mice. DNA sequence
of all constructs was verified by DNA sequencing. The mouse p65 cDNA was obtained from the
Dr. David Baltimore lab.
Generation of Transgenic Mice: The aP2-p65 transgene was microinjected into the
pronuclei of fertilized mouse eggs taken from superovulated C57BL/6 F1 females. Injected
embryos were implanted into the oviducts of surrogate females of the same genetic background.
Transgenic founders were selected for breeding for new generations on a C57BL/6 background.
New-born pups were weaned at 3 week age. Transgenic mice and wild-type (WT) littermate
share identified with genotyping PCR, and WT littermates were used as controls. These
procedures were conducted in the transgenic core facility at the Pennington Biomedical Research
Center. The aP2-p65 mice (Tg mice) used for experiment are heterozygotes.
DNA Preparation and Genotype PCR: DNA was prepared from 0.5 cm tail sample at 3
week in age using the proteinase K protocol. The tissues were digested with proteinase K
(FisherBiotech, Houston, TX) at 55 oC overnight. DNA (300ul) was purified with 0.5 ml phenolchloroform and centrifuged at 14, 000 x g at room temperature. Cold ethanol (0.5ml 100%) was
added to precipitate DNA. After washed with 75% ethanol and air dried, the DNA pellets were
dissolved in 50ul DNase-free H2O and stored at -20°C before genotype PCR was performed. The
genotype PCR was performed with Alpha PTC DNA engine systems. The PCR primers were
ordered from Sigma: Forward primer: GGACTTCTCTGCTCTTTTGAGTCAGA. Reverse
11

primer: CCTACTCAGACAATGCGATGCAA. The reaction mixture contained: 200ng DNA,
0.5ul thermol buffer, 50nmM NTP, forward primers, reverse primers and 2.5U Tagman enzyme.
The reaction conditions were: 94°C for 5 min, 94°C for 45 sec, 60°C for 45 sec, 72°C for 45 sec
plus 33 cycles of 94°C for 45 sec, then 72°C for 5 min and 4°C forever. PCR products were
running in 1% Agarose gel plus EB and final results were detected in a Bio-Rad ultraviolet
detector.
RNA Preparation and Quantitative Real Time RT-PCR: Mice were sacrificed after a
6-h fast and the epididymal fat pad (for epididymal WAT), subcutaneous fat (for subcutaneous
WAT), BAT, liver, and muscle were collected immediately and kept in liquid nitrogen. Total
RNA was prepared using 1ml TRIzol Reagent (Invitrogen) for each sample according to the
manufacturer’s instructions. The homogenate-chloroform was mixed with 200 ul of chloroform
and centrifuged at 18,000 x g at 4°C for 15 min for phase separation. For RNA precipitation,
300ul of aqueous supernatant was transferred to a 1.5 ml-Eppendorf tube, mixed with 500ul of
isoproponal, incubated at room temperature for 10 min, and then centrifuged at 18,000 x g at 4°C
for 15 min. The precipitated RNA pellet was washed by 500 ul of 75% ethanol, centrifuged at
18,000 x g at 4°C for 5 min, the ethanol was removed, and the RNA pellet was allowed to dry in
air for 5 to 10 min. The RNA pellet was dissolved in 20ul of RNase-free H2O and stored at 80°C. p65 expression was examed by real time RT-PCR. 18s was used as an internal control.
Real time RT-PCR was performed on an ABI PRISM 7700 sequence detector. The reaction
mixture contained: 15 ng RNA, PCR buffer, 5.5 mM MgCl2, 5 U RNAse inhibitor, 12.5 U
MuLV Reverse Transcriptase, 1.5 U AmpliTaq Gold DNA polymerase, dATP, dCTP, dTTP and
dGTP each 0.3 mM, 500 nM forward primers, 500 nM reverse primers, 200 nm Taqman probes,
(Applied Biosystems). The reaction conditions were: 48°C for 30 min for RT; one cycle of 95°C
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for 10 min plus 40 cycles of 95°C for 15 sec and 60°C for 1 min for PCR. PCR products were
sequenced. The relative level of mRNA was normalized to constitutive expression of 18s mRNA.
Data are reported as means ± SE.
The primers used in the phenotype study of Tg mice were all from Applied Biosystems,
including ACDC (Mm00456425_m1), aP2 (Mm00445880_m1), leptin (Mm00434759_m1), IL-6
(Mm00446190_m1), F4/80 (Mm00802530_m1), TNF-α (Mm00443258_m1), PPARγ
(Mm00440945_m1), FAS (Mm00662319_m1), SREBP (Mm00550338_m1), SCD1
(Mm00772290_m1), LPL (Mm00434770_m1), HSL (Mm00495359_m1), MCP1(Mm00441242_m1), IkBa (Mm00477798_m1), IL-10 (Mm00433859_m1), IL-18
(Mm00434225_m1), CD11c (Mm00434455_m1), Pref-1 (Mm00494477_m1).
Adipogenesis Study in Vitro: In this study, we collaborated with Dr. Barbara Kozak and
Dr. Jaroslaw Staszkiewicz. Mice at 5 weeks in age were used for collection of the preadipocytes
in the adipogenesis study. Each group had 5 mice. Their epididymal fat and inguinal fat were
collected, minced and digested with collagenase type I (2 mg/1 ml; Worthington Biochemical,
Freehold, NJ) in a shaking bath for 1h at 37°C. The cell suspension was filtered through a 70 µm
cell strainer (Becton Dickinson Labware, NJ) followed by centrifugation (360 × g, 5 min, RT).
Pelleted cells were resuspended in 1 ml red blood lysis buffer (Sigma Co., St. Louis, MO) and
centrifuged as above. The isolated cells were plated in 100 mm Petri dishes (p = 0) in Dulbecco's
Modified Eagle Medium DMEM/F12; Invitrogen, Carlsbad, CA) supplemented with 1%
antibiotic solution and 15% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA). Subconfluent
primary cultures were trypsinized (0.05% trypsin/0.53 mM EDTA; Life Technologies, New
York, NY) followed by immunomagnetic cell sorting. For in vitro adipogenic differentiation,
cells were replated in 12-well culture plates (Corning, Corning, NY) at the density of 105/well
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and maintained in complete medium until confluent (considered as a day 0). Thereafter, the cells
were exposed to an adipogenic medium containing DMEM/F12, 5% FBS, 1% antibiotic solution,
0.5 mM isobutylmethylxanthine, 1.7 µM insulin and 1 µM dexamethasone for 2 days. For the 6
days of adipogenesis, the culture was collected at days 0, 2, 3, 6 and 8 for RNA purification.
Preparation of Whole Cell Extracts: Tissue samples were rinsed with PBS and then
harvested in a nondenaturing buffer containing 10 mM Tris (pH 7.4), 150 mM NaCl, 1 mM
EGTA, 1 mM EDTA, 1% Triton X-100, 0.5% Nonidet P-40, 1 μM phenylmethylsulfonyl
fluoride, 1 μM pepstatin, 50 trypsin inhibitory milliunits of aprotinin, 10 μM leupeptin, and 2
mM sodium vanadate. Samples were sonicated for 3x6 times on ice and centrifuged at 15,000
rpm at 4°C for 15 min. Supernatants containing whole cell extracts were analyzed for protein
content by BCA analysis (Pierce) according to the manufacturer’s instructions. Supernatants
were stored at -20 °C prior to Western immunoblotting.
Western Immunoblotting: Homogenates were separated in 8% polyacrylamide gels
containing sodium dodecyl sulfate (SDS) and transferred to PDVF membranes in 25 mM Tris,
192 mM glycine, and 20% methanol. After the transfer, the membrane was blocked in 4% milk
for 30 min and incubated with the primary antibodies p65 (#P3363, Santa Cruz, MA). The signal
was visualized with horseradish peroxidase-conjugated secondary antibodies from Sigma.
Tubulin (#4699-9555, Biogenesis, Kingston, NH) was used as an internal control.
Nuclear Magnetic Resonance: Body composition was measured using quantitative
nuclear magnetic resonance (NMR) as described previously [59]. In the test, conscious and
unrestrained mice were placed in a small tube individually and the tube was inserted into a
Minispec Mn10 NMR scanner for diction of body composition (Brucker, Canada, Milton ON,
Canada). The fat and lean mass were recorded within 1 min.
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General Follow-up and Blood Glucose Analysis: Follow-up of body weight and body
composition of the mice were performed every two weeks. The mice were fasted overnight and
physically examined the next morning. The body compositions were detected as described above.
The relative percent of body fat content and muscle content were adjusted according to
individual body weight. Blood glucose concentrations were measured with a One-touch blood
glucose monitor (Freestyle, Abbott) every four weeks. Whole blood was collected with
heparinized capillary tubes (Fisherbrand, PA) and centrifuged at 4 °C at 4000 X for 20 min to
obtain serum samples. Serum samples were individually labeled and kept at -20°C before testing.
At the age of 16 weeks, the diet of the mice was switched from a chow diet to a high-fat diet and
the follow-up went on as described before. Body weight and blood glucose results are presented
as an average ± SD.
Food Intake: Food intakes of mice were evaluated to determine whether there is any
difference between WT mice and Tg mice. The test lasted for 3 days. Mouse body weights prior
to and after the test were measured. At the beginning, food weight was measured and at the end
of the test, left food not eaten was carefully collected and weighed. The difference of food
weight prior to and after the test adjusted by body weight stands for the food intake of the mice.
Results are presented as an average ± SD.
Indirect Calorimetry: Indirect calorimetry measurement was performed with
Comprehensive Laboratory Animal Monitoring System (Columbus Instruments, Columbus, OH)
in the Pennington Biomedical Research Center. The experiment lasted for a week, during which
mice were free to consume food and water. The mice were housed individually in the metabolic
chamber. Ambient room temperature ranges between 23 and 25°C. Only parameters obtained in
steady-state conditions were used for final calculations and evaluations (steady state refers to the
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state as ≥3 min of VO2 within 10%, of respiratory quotient within 5%, and of air flow through the
canopy system within 10%). After 48 h of adaptation, the data involving energy expenditure,
respiratory exchange ratio (RER), and spontaneous physical movement were simultaneously
recorded for each individual mouse and used in analysis of the metabolic phenotype.
Intraperitoneal Insulin Tolerance (ITT): ITT was conducted by intra-peritoneal (i.p.)
injection of insulin (I9278, Sigma) at 0.75 U/kg body weight in mice after a 4 hour fast as
previously described (Gao et al., 2007). Blood glucose was monitored in the tail vein blood using
the FreeStyle blood glucose monitoring system (TheraSense, Phoenix, AZ).
Glucose Tolerance Test (GTT): For glucose tolerance tests, mice were fasted overnight,
and glucose (2.5 g/kg body wt) was administered intraperitoneally the next morning. Then tail
vein blood glucose concentrations were measured at 0 min, 30 min, 60 min, 120 min and 180
min with Freestyle One-touch glucose monitor (TheraSense, Phoenix, AZ).
Immunohistological Staining: Fresh epdidymal fat and liver tissue were collected and
fixed in fresh 4% formalin for at least 24 hrs, then washed in Phosphate Buffered Saline (PBS)
buffer for 2 hrs. After mounting dehydrated in 70%, 95% and 100% ethanol and treated with
xylene, the tissues were embedded into melted paraffin. The tissue slides were obtained through
serial cross-section cutting at 5 um thickness and processed with a standard procedure including
dewaxed with xylene, hydrated with 100%, 95%, 80% and 70% step by step, treated with 0.2%
H2O2, antigen unmasked in 0.01M sodium citrate buffer, treated with 0.2% Triton-x-100, and
incubated with goat serum diluted in 1%BSA. The slides were then blotted with a monoclonal
primary antibody of F4/80(sc-71087, Santa Cruz) at 1:200 dilution. After being washed with
PBS, the slide was incubated with a biotinylated secondary antibody (mouse IgG) in ABC kit.
The slides were then incubated with the ABC elite reagent (PK-6101) and color reaction was
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performed using the DAB substrate kit (SK-4100) for myosin I and AEC substrate kit (AEC101,
Sigma) for F4/80 according to instructions by the manufacturers.
Preadipocyte Adipogenesis Study: The experiment was done with the collaboration of
Drs. Barbara Kozak and Jaroslaw Staszkiewicz. The detail methodology has been described in
the paragraph of adipogenesis study in vitro in chapter 2.
Fluorescent Staining: Differentiated cells were fixed with 10% formalin for 1 h at RT
followed by staining with 300 nM DAPI 10 µg/ml BODIPY® 493/503 (Invitrogen, Carlsbad, CA)
in PBS for 20 min at RT. After washing 3 × 5 min in PBS, cells were imaged with a Plan Fluor
DL 10× objective using a Nikon Eclipse TE2000-U inverted microscope equipped with a
CoolSnap camera. Images of random areas were captured and stored with Metamorph imaging
software. Fluorescence was measured on a FLEXstation Benchtop Scanning Fluorometer
(Molecular Devices, Sunnyvale, CA) with excitation and emission wavelengths of 490 & 545 nm
(Bodipy), and 355 & 450 nm (Dapi), respectively. Results are presented as a mean ratio
BODIPY/DAPI ± SD.
Primary Macrophage Study: Primary peritoneal macrophages were isolated from Tg
mice and WT littermate of 24-week-age, as what we described before[59]. The macrophages
were induced intraperitoneally by injection of 2 ml of sterilized solution of 2% starch (Sigma
85643). The macrophages were harvested 3 days later with 20 ml of cold PBS in lavage and then
cultured in DMEM (supplemented with 10% FBS and 50µg/ml gentamicin) in a 100-mm culture
dish. Three days later, the cells were transferred to 35-mm tissue culture dishes and treated with
or without LPS (2ng/ml, Sigma) in serum-free RPMI 1640 medium. 2 hrs later, median was
removed and cell RNA was collected and purified.
Statistical Analysis: Statistical analysis for food intake, body weight, body content,
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indirect calorimetry, fasting blood glucose, ITT, GTT, blood lipid profile, blood cytokine
level and all real time RT-PCR in tissues was performed using two-tailed unpaired Student’s ttest for WT littermates versus Tg mice.
RESULTS
Generation of Transgenic Mice: The construction of aP2-p65 plasmid is illustrated in
Fig. 1A. One male and two female founders of the Tg mice were born in Dec. 26, 2006 and
delivered to our lab from the transgenic core facility. The genotype PCR was conducted in all of
the three founders and their positivity was confirmed. Transgene was indicated by a PCR product
of 400bp in the tissue of positive mice. The result from founder 2 is presented in Fig. 1B. All of
the founders were used to breed with C57/B6 WT mice to amplify each colony. The founder 2
was used in the following study for its productivity in breeding. In this study, male transgenic
(Tg) mice were used in the following studies. Age-matched WT littermates were used as the
control.
p65 Expression in the Adipose Tissue of Transgenic Mice: To confirm p65 expression
in adipose tissue in the transgenic mice, p65 mRNA levels were examined in different tissues,
and the expression was compared between Tg and Wt mice. In the study, samples were collected
from Tg and WT mice with 6 in each group. The results from qRT-PCR showed that the p65
mRNA level was significantly elevated in adipose tissue of Tg mice. The elevation was observed
in both WAT and BAT, but not in other tissues such as liver. In the Tg mice (Fig 2 A, B, and C),
the p65 protein level was also elevated in the adipose tissue. These results demonstrated that NFκB p65 overexpression is achieved specifically in the adipose tissue of Tg mice.
p65 Expression in Adipogenesis: Preadipocytes were isolated from the inguinal fat pad
and used in vitro in a differentiation assay. Three mice were used in each group. Day 0 was the
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starting point and day 6 was the peak point of differentiation. Expression of p65 was determined
by mRNA and compared between Tg and WT cells. At day 0, there was no difference in p65
mRNA levels in the two groups (Fig 2F). After differentiation, the p65 mRNA level was 4 fold
higher in the Tg cells, suggesting that the aP2 promoter activity was activated in mature
adipocytes and this leads to expression of the recombinant p65 in mature adipocytes.
Energy Metabolism: To evaluate the energy metabolism, we tested the energy
expenditure in the mice. In our study, energy expenditure was induced by overexpression of NFκB p65 in the adipose tissue. This led to prevention of diet-induced obesity. The energy
expenditure was studied in the mice on both chow and high fat diet (HFD). Food intake, physical
activity, energy expenditure, oxygen consumption and substrate utilization were monitored using
the metabolic chamber. There was not a significant difference in food intake and spontaneous
physical activity on the chow diet between the two groups (Fig. 3, A and B). However, energy
expenditure and oxygen consumption were increased in the Tg each group mice during both day
and night time (Fig. 3, C and D). The fold increase in energy expenditure was much higher at
night in the Tg mice (Fig. 3C).
On the high-fat diet, the food intake in Tg mice was even higher than that of WT mice
(Fig. 4A). But energy expenditure was also increased in the Tg mice (Fig. 4, C and D). However,
the fold increase was smaller at night time. The RER value was not changed in the Tg mice in
chow or HFD (Fig. 3E and 4E), suggesting that substrate utilization was not changed in the Tg
mice. This group of data suggests that p65 over expression in adipose tissue leads to an increase
in energy expenditure in transgenic mice.
Body Weight: The body weight was recorded every two weeks in the study from 6
weeks in age when the Tg had the same body weight as the Wt mice. From 6 to 16 weeks on the
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Figure 1. Generation of aP2-p65 transgenic mice (Tg mice). (A) The construction of plasmid
vector for aP2-p65 expression cassette. The mouse p65 cDNA was obtained through PCR over
a vector template (from Dr. David Baltimore lab). The PCR product was cloned into a
Bluescript plasmid at the downstream of the aP2 (FABP4) gene promoter at Spe I/Not I sites.
The aP2-p65 expression cassette was then inserted into pcDNA3.1 plasmid at Hind III/Not I
sites to gain the Poly A signal. After confirmation by DNA sequencing, the aP2-p65-poly A
fragment was purified and used for production of the transgenic mice in C57BL/6J strain. The
transgenic mice were made in the core facility at PBRC; (B) Genotype PCR image of the aP2p65 transgenic mice. At the age of 3 weeks, the pups were weaned and their tail tissue was
collected to extract DNA. Transgenic gene was confirmed by genotype PCR with a PCR
product of 400bp size.
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chow diet, average body weight was increased by 66% (21 g to 35 g) in the WT mice (Fig. 3F),
fat content (adiposity) was increased by 160% (10% to 26% BW) (Fig. 3G), and the percentage
of lean mass was reduced by 20% (80% to 64%) (Fig. 3H). In the Tg mice, the average body
weight was only increased by 5% (20 g to 21 g), fat content was increased 78% (9% to 16% BW)
(Fig. 3G), and the percentage of lean mass was reduced by 12% (82% to 72%) (Fig. 3H). These
data suggest that p65 is able to prevent adipose tissue growth in adulthood, and protect the Tg
mice from adulthood obesity.
The phenotype study was conducted on HFD in mice, which were fed on HFD at 16
weeks in age. In the WT mice, average body weight was increased by 48% (Fig. 4F), fat content
(adiposity) was increased by 59% (Fig. 4G), and the percentage of lean mass was reduced by
21% on HFD for 10 weeks (Fig. 4H). In the Tg mice, changes in this group of parameters are
much smaller. The increases were 22% (32 g to 39 g) in body weight and 44% (16% to 23%) in
the adiposity. The decrease was 8.2% (73% to 67%) in the lean mass, suggesting that adipose
tissue specific overexpression of p65 attenuated weight gain and decreased adipose tissue
expansion induced by high-fat diet. Mouse growth was not influenced by p65 overexpression as
the body length was identical between the two groups (Fig. 3I). These data suggest that p65 is
able to prevent adulthood obesity, and protect the Tg mice from diet-induced obesity. The
increase in energy expenditure may be responsible for the phenotype in body weight.
Insulin Sensitivity: In the Tg mice, the lean phenotype may increase insulin sensitivty.
To test this possibility, insulin sensitivity was examined by ITT. The fasting glucose was not
changed in the Tg mice from 6 to 16 weeks in age (Fig. 5A). At 14~15 weeks in age, an insulin
intolerance test (ITT) was conducted after 4 hr fasting. The Tg and Wt mice did not exhibit a
significant difference in the test although there was a big difference in their body weight.
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Figure 2. p65 expression level in different tissues. (A, B, C and F) Real time RT-PCR was
performed to test p65 mRNA level in white adipose tissue, brown adipose tissue, liver and in
adipogenesis study. (D, E) P65 protein expression in different tissues demonstrated with
Westernblotting test. (A) Relative p65 mRNA level in white adipose tissue; (B) Relative p65
mRNA level in brown adipose tissue; (C) Relative p65 mRNA level in liver; (D) P65 protein
expression in white adipose tissue; (E) P65 protein content in liver; (F) Relative p65 mRNA
level in adipogenesis study in vitro. Preadipocytes were isolated from inguinal fat pad of 5week-old mice. N=3 mice for Preadipocytes were induced differentiation after confluence. At
day 0 and day 6, RNA were extracted from some cells. p65 mRNA level was determined by
real time RT-PCR. For A-C, n=6 in wild-type (WT) or transgenic (Tg) group. For F, n=3 in
each group, Values are the mean ± SE. *P<0.05, **P<0.001 by Student’s t test.
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No difference was detected between the two groups of mice on either chow diet or high-fat diet
(Fig. 5 B and C). This result was unexpected and will be discussed later.
Glucose Tolerance: We also conducted the glucose tolerance test in the Tg mice to
evaluate the pancreatic function. The study was conducted on the chow diet. Blood glucose
levels were recorded at 0min, 30min, 60min, 120min and 180min after injection of glucose.
After quantification of area under the curve, we found no difference between the two groups of
mice (Fig 5, D and E). The data suggest that insulin secretion was not changed in the Tg mice.
WAT: The reduced adulthood adiposity in the Tg mice led us to examine structure and
function of WAT. The epididymal fat pad was used in the analysis of adipocyte size and gene
expression. The fat pad and adipocyte size were both reduced in the Tg mice (Fig. 6, A and B).
The fat pad was 60% less in mass and adipocyte size was 40% smaller in the Tg mice. In gene
expressions, mRNA was quantified by qRT-PCR in the adipose tissue. In the Tg tissue,
adipocyte markers such as adiponectin and leptin were more than 50% lower than those in WT
(Fig. 6C). The leptin mRNA was only 20% of that in the WT tissue. The aP2 and PPARγ mRNA
was also much lower. The fat synthesis-related genes, FAS and SREBP were about 50% lower
(Fig. 6D). These data suggest that fat synthesis and storage are decreased in the Tg mice.
However, the genes related to lipolysis such as LPL and HSL were also reduced in Tg tissues
(Fig. 6E). The data suggest that P65 overexpression is able to reduce triglyceride accumulation in
adipocytes and the mechanism is related to inhibition of PPARγ function.
As expected, inflammatory cytokines, such as TNF-α, IL-1, IL-6, and MCP-1, were
remarkably elevated by p65 in adipose tissue (Fig. 6F). Macrophage infiltration into the adipose
tissue was also increased in the Tg mice. mRNA of Macrophage markers, such as CD11 and
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F4/80, were elevated (Fig. 6G). F4/80 protein was increased in the adipose tissue of Tg mice (Fig.
6B). The inflammation may contribute to the inhibition of PPARγ function in the adipose tissue.
Adipogenesis in Vitro: The reduced PPARγ activity was associated with the lean
phenotype in the Tg mice. According to our previous study, the PPARγ inhibition may be a
direct consequence of p65 over expression in adipocytes. However, inflammation in the adipose
tissue may also contribute to the inhibition. To test the direct effect of p65 in adipocytes, we
conducted an adipogenesis assay in vitro using primary preadipocytes. The preadipocytes were
isolated from inguinal fat and differentiated in the presence of adipogenic cocktail containing
Pioglitazone. The differentiation was monitored by gene expression and TAG accumulation. In
the Tg cells, expression of preadipocyte marker Pref-1 was not changed before differentiation,
but significantly higher after differentiation compared to WT cells (Fig. 7A).
Adipokines such as adiponectin and leptin were not detectable in the preadipocytes, and
their expression was 50% lower in the Tg cells after differentiation (Fig. 7, B and C). In
differentiated cells, TAG abundance was 50% lower in the Tg cells (Fig. 7, D and E). The data
suggest that preadipocyte number was not reduced in the Tg mice, but their potential in
adipogenesis was decreased compared to WT cells.
The PPARγ mRNA was significantly lower in the Tg preadipocytes, and the difference
was further increased after differentiation (Fig. 7F). The PPARγ target gene aP2 was also
significantly lower in the Tg cells after differentiation (Fig. 7G). This is consistent with
reduction in adiponectin (PPARγ target gene) expression (Fig. 7B). These data suggest that the
PPARγ suppression may be responsible for the reduced differentiation potential in the
preadipocytes of Tg mice. Since p65 expression was increased by several fold in the Tg cells
after differentiation (Fig. 2F), the PPARγ inhibition is likely a result of the p65 overexpression.
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Expression of inflammatory cytokines may not be required for the PPARγ inhibition in this
system.
Inflammation in Other Tissues: To determine the tissue specificity of inflammation
from p65 overexpression, we also tested gene expressions in brown adipose tissue, liver and
skeletal muscle. Similar to the white fat, the brown fat exhibited an increase in mRNA for TNF-α,
IL-1 and IL-6 in the Tg mice (Fig. 8A). Macrophage chemoattractant protein 1 (MCP-1) and
macrophage marker F4/80 were also increased in the brown fat (Fig. 8B). Unlike in the adipose
tissues, the liver and muscle did not exhibit an increase in inflammatory genes (Fig. 8, C and D).
In combination with data in Fig. 2, these data suggest that inflammation was increased
specifically in the adipose tissue of Tg mice.
DISCUSSION
P65 and Metabolism: The current concept about NF-κB in the regulation of metabolism
is derived from evidence of IKK2 transgenic mice [60] and cellular models in which NF-κB
activity is modulated by TNF-α or NF-κB related genes [51].
The exact function of NF-κB in adipose tissue has not been demonstrated in transgenic
mice. In our study, we successfully established the transgenic mouse, and then characterized the
metabolic phenotype of the mice. The results suggest that P65 overexpression in adipose tissue is
able to increase whole body energy expenditure. The increase is able to prevent adulthood
obesity, and protect the mice from dietary obesity. The energy expenditure is not from a change
in physical activity or food intake. The reproductivity and development of the Tg mice was
normal.
The mechanism for the lean phenotype was associated with inhibition of PPARγ activity
in the Tg mice. Our data demonstrate that expression of the recombinant p65 is dramatically
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Figure 3. Energy metabolism in Tg mice and the WT mice on chow diet. P65 overexpression in
WAT increased energy expenditure in aP2-p65 C57BL/B6 mice. Food intake and energy
expenditure were examined using the metabolic chamber (12 weeks in age). (A) Food intake.
Food intake was monitored daily for 3 days. Average daily food intake (g) was converted into K
calorie and normalized with body weight (kg) and 24 hours; (B) Spontaneous physical activity.
The frequency of horizontal movement was shown for day time and night time; (C) Energy
expenditure. The unit is K caloric per kilogram body weight every hour; (D) Oxygen
consumption. The unit is ml volume oxygen in kilogram body weight per hour; (E) Substrate
utilization, expressed by respiratory exchange ratio (RER), which is a volume ratio of oxygen
consumed versus CO2 exhaled; (F) Body weight; (G) Body fat content in percentage of body
weight. This was determined by NMR; (H) Body muscle content in percentage of body weight;
(I) Picture of experimental animals. It was taken on chow diet (at 20 weeks in age). For A-E,
n=8, For G-H, n=10 in WT or Tg group. Values are the mean ± SE. *P<0.05, **P<0.001 by
Student’s t test.
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Figure 4. Energy metabolism in Tg mice and the WT mice on HFD. P65 overexpression in
WAT increased energy expenditure in aP2-p65 C57BL/B6 mice. Food intake and energy
expenditure were examined using the metabolic chamber (12 weeks in age). (A) Food intake.
Food intake was monitored daily for 3 days. Average daily food intake (g) was converted into K
calorie and normalized with body weight (kg) and 24 hours; (B) Spontaneous physical activity.
The frequency of horizontal movement was shown for day time and night time; (C) Energy
expenditure. The unit is K caloric per kilogram body weight every hour; (D) Oxygen
consumption. The unit is ml volume oxygen in kilogram body weight per hour; (E) Substrate
utilization. This is expressed by respiratory exchange ratio (RER), which is a volume ratio of
oxygen consumed versus CO2 exhaled; (F) Body weight; (G) Body fat content in percentage of
body weight. This was determined by NMR; (H) Body muscle content in percentage of body
weight; (I) Mouse picture. It was taken on HFD for 10 weeks (at 26 weeks in age). For A-E,
n=8, For F-H, n=10 in WT or Tg group. Values are the mean ± SE. *P<0.05, **P<0.001 by
Student’s t test.
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Increased in mature adipocytes, but not in the preadipocytes. This pattern of expression is
expected and is responsible for the inhibition of PPARγ function in the mature adipocytes. In
addition to adipocytes, expression of the p65 is increased in macrophages, and this may
contribute to the elevated activity in macrophages. In adipose tissue, the inflammation is
increased as indicated by macrophage infiltration and inflammatory gene expression.
The inflammation may contribute partially to the inhibition of PPARγ function by
promotion of NF-κB activity. TNF-α expression is increased in the adipose tissue, and it may
inhibit adipocyte function through targeting PPARγ-responsive genes such as LPL [34], and
perilipins [35].
P65 and Adipogenesis: In this study, we found that the body fat mass of Tg mice is
much less than WT mice both on chow diet and high-fat diet. The size of adipocytes from Tg
mice are 40% smaller. Furthermore, the expression of PPARγ and its target genes (aP2, and
adiponectin) are decreased in adipose tissue and differentiated adipocytes from Tg mice. PPARγ
is essential in adipogenesis, which has been showed in in vitro preadipocyte experiments[61] and
the animal model of adipose tissue specific knockout of PPARγ [62]. The study of preadipocyte
differentiation in vitro showed that preadipocyte number is not reduced in the Tg mice, but their
differentiation was decreased. Gene analysis shows that the baselines of aP2, PPARγ,
adiponectin, leptin and pref-1 are similar in the two groups before differentiation. However, after
differentiating, all of the genes are lower in the aP2-p65 cells. The mRNA level of pref-1, which
is mainly expressed in preadipocyte, was increased in the Tg cells after differentiation (Fig 7 C).
A high level of pref-1 is connected with less adipogenesis[63], These data support that the
adipose tissue specific overexpression of NF-κB P65 inhibited preadipocyte differentiation into
mature adipocytes mainly through PPARγ inhibition.
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P65 and Insulin Sensitivity: In our study, Tg mice have less possibility to gain weight
and body fat mass on both chow diet and high-fat diet. Their adipocyte size is also significantly
smaller than WT adipocytes. According to the phenomenon, we had expected to see better
insulin sensitivity in Tg mice than their WT littermates. But we observed no meaningful
improvement in insulin sensitivity either on chow diet or on high-fat diet, which was
determined with fasting blood glucose levels and an insulin tolerance test. The results indicate
that even though Tg mice did not develop obesity, the residential chronic inflammation in the
adipose tissue plays a great effect on the systemic insulin effect. The Tg mice had an increased
amount of adipose tissue macrophages with higher IL-6 and TNF-α levels. According to the
findings in aP2-MCP-1 transgenic mice[64], we hypothesize that both the paracrine and the
endocrine effects of inflammatory cytokines contributed to the development of insulin
resistance in Tg mice. TNF-α and IL-6 might work locally on adipocytes, and skeletal muscle
and the liver, causing alterations in metabolic and endocrine functions. In local adipocytes,
increased lipolysis and decreased FFA uptake lead to elevated release of NEFAs, contributing
to the exacerbation of insulin resistance in Tg mice. Furthermore, TNF-α and IL-6 may block
the classic insulin signaling pathway through inhibition of phosphorylation of IRS proteins.
However, it is difficult to quantify the degree to which each of these effects contributes
to the development of insulin resistance yet. Besides, PPARγ, adiponectin and leptin mRNA
levels were also reduced in the WAT of Tg mice, suggesting that the anti-insulin resistance
mechanism is impaired too. Therefore, our future research may focus on the insulin signaling
pathway in adipose tissue.
A recently published study might provide another explanation for this phenomenon. The
aP2-Lepr-b transgenic mouse model was used as an adipose tissue specific db/db model.
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Figure 7. Adipogenesis Study in vitro. Inguinal fat tissue was collected from both aP2-p65
transgenic mice and wild-type mice (at the age of 5 weeks). After digested with collagenase, the
preadipocytes were isolated and cultured in vitro. When the cells reach confluence, adipogenic
induction medium was added to induce differentiation. At the induction day 0, 2, 3, 6 and 8,
pictures were taken and RNA was taken from part of cells. (A, B and C). Change of adipocyte
marker genes mRNA level through adipogenesis. (A) Pref-1 relative mRNA level through
adipogenesis; (B) Adiponectin relative mRNA level through adipogenesis; (C) Leptin relative
mRNA level through adipogenesis; (F) aP2 relative mRNA level through adipogenesis; (G)
PPARγ relative mRNA level through adipogenesis; (D) Fluorescence images taken on the 8 day
of differentiation of the preadipocytes, demonstrating the adipogenesis of WT mouse and Tg
mice; (E) Guantification of triglyceride in adipocytes. BODIPY and DAPI staining was used to
illustrate the TG amount in the mature adipocytes. Green areas demonstrate the triglyceride
droplets, blue areas demonstrate nucleus. BODIPY/ DAPI means the triglyceride amount
adjusted by cell amount. For A, B, C, F and G, n=3 in WT or Tg group. For D and E, n=6
pictures of cells were taken in wild-type or aP2-p65 group to calculate the average of the
quantification. Values are the mean ± SE. *P<0.05, **P<0.001 by Student’s t test.

32

A. Inflammation genes in BAT
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Figure 8. Inflammation status in Brown Adipose Tissue and Other Tissues. Brown adipose
tissue, liver and skeletal muscle was collected at the age of 20 weeks and RNA was extracted.
(A) Inflammation gene expression in BAT. Relative mRNA folder of TNF-α, IL-1 and IL-6 is
determined by real time RT-PCR; (B) Relative mRNA folder of macrophage markers F4/80,
MCP1 in BAT, determined by real time RT-PCR; (C) Relative mRNA folder of inflammation
gene TNF-α and IκBα in liver, other inflammation genes were not detected in real time RTPCR. (D) Relative mRNA folder of inflammation gene IL-1, IL-6 and TNF-α in liver. For A-D,
n=6 in WT or Tg group. Values are the mean ± SE. *P<0.05, **P<0.001 by Student’s t test.
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Similar to our Tg mice, the aP2-Lepr-b mice had less adipogenic capacity but more severe
insulin resistance than db/db and WT mice when fed a high-fat diet[65]. Morphologic
examination showed that ectopic lipid deposition happened widely in heart tissue, liver and
other tissues of the aP2-Lepr-b mice. The findings suggest that the function of the adipocyte to
store surplus calories during overnutrition has a great effect on systemic insulin resistance. Thus
we might hypothesize that the impaired adipogenesis in adipose tissue of Tg mice also induces
ectopic lipid deposition in other tissues, leading to the systemic insulin resistance. Further study
may switch to other organs and tissues including liver and skeletal muscle, which may take
more important role in systemic metabolism.
P65 and Inflammation: In this study, we demonstrated that overexpression of NF-κB
P65 caused chronic inflammation in adipose tissue. This is supported by an increase in
macrophage infiltration, type 1 macrophages, and expression of inflammatory cytokines (TNF-α,
IL-1, IL-6, and MCP-1). The inflammation may be a result of elevated expression of p65 in
macrophages since p65 mRNA is increased in the macrophages of Tg mice. The p65 expression
enhances macrophage expression of inflammatory cytokines in the basal condition, and as well
in LPS-stimulated condition. The inflammation is expected since NF-κB p65 is a major
transcriptional activator for inflammatory genes.
The expression of p65 in adipocytes may also contribute to the inflammation. However,
the direct effect may be limited since the inflammatory activity of adipocytes is much lower than
that of macrophages [66]. It is possible that adipocytes contribute to the inflammation by
secretion of MCP-1 and IL-6, which promote macrophage infiltration and activation.
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CHAPTER 3
SUMMARY AND CONCLUSION
In this study, we made the fat-specific transgenic mice for NF-κB p65. The p65
expression was observed in adipocytes and in macrophages. This expression pattern leads to a
lean phenotype in the Tg mice with elevated energy expenditure and a defect in adipogenesis.
This lean phenotype prevents adulthood obesity and dietary obesity. However, it does not
provide benefit to the protection of systemic insulin sensitivity. The underlying mechanism
might be ectopic fat deposition in the Tg mice. There is no difference between the Tg and WT
mice in insulin sensitivity on Chow (low fat) or HFD. The p65 gene modification seems to have
no influence on reproductivity, embryo development and postnatal growth in the Tg mice.
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